Edition:
United Kingdom

Insmed Inc (INSM.OQ)

INSM.OQ on NASDAQ Stock Exchange Global Select Market

16.77USD
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
$16.77
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
373,613
52-wk High
$33.09
52-wk Low
$11.31

About

Insmed Incorporated is a global biopharmaceutical company. The Company’s product ARIKAYCE (amikacin liposome inhalation suspension) is developed for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $2,392.91
Shares Outstanding(Mil.): 76.50
Dividend: --
Yield (%): --

Financials

  INSM.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -3.04 -- --
ROI: -92.57 8.94 14.48
ROE: -112.72 10.07 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates